Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer

Area of Science:

• Urology
• Oncology
• Diagnostic Imaging

Background:

• Prostate cancer diagnosis often involves invasive biopsies.
• Multiparametric MRI (mpMRI) shows promise in detecting significant prostate cancer.
• Biomarker tests can further refine risk assessment.

Purpose of the Study:

• To review studies on the combined use of biomarker tests and mpMRI for prostate cancer detection.
• To evaluate clinical outcomes, including avoided biopsies and missed cancers, of integrated diagnostic strategies.

Main Methods:

• Narrative review of relevant clinical studies.
• Analysis of studies reporting data on biomarker tests and mpMRI.
• Examination of clinical outcomes data related to diagnostic strategies.

Main Results:

• Combined biomarker and mpMRI strategies can effectively predict GG ≥2 prostate cancer.
• Various testing strategies demonstrate potential for reducing unnecessary biopsies.
• Careful implementation is needed to minimize the rate of missed GG ≥2 cancers.

Conclusions:

• Integrating biomarker tests with mpMRI offers a viable approach to optimize prostate cancer diagnosis.
• This combined approach can enhance diagnostic accuracy and patient management.
• Further research should focus on refining these strategies for clinical practice.